News

The appointment of Mr Friel to chairman is believed to be part of PerkinElmer’s 2007 leadership succession plan designed to support the company’s growth strategy and provide strong

Based on the company’s dual priming oligo (DPO) technology, the Seeplex diarrhea ACE detection tests for 10 bacteria (Salmonella species, Shigella species, Campylobacter species, Vibrio species, C difficile

Dr Toleikis is a seasoned and experienced biotechnology executive, with over 20 years of research, intellectual property, management and business experience in the pharmacology and biotechnology sectors, the

The Malaysian Ministry of Health will provide a grant of MYR5 million to support this work which will be executed by GeneNews (Malaysia) Sdn Bhd, a subsidiary of

The patent, which was granted in March 2009, covers the use of a specific polymer for the prophylactic and therapeutic treatment of rhinovirus infections. Andreas Grassauer, CEO and

K2M has obtained the worldwide exclusive rights for all spinal applications of this material through an agreement with Promethean Surgical Devices in November 2008. In furtherance of K2M’s

For the first quarter of 2009, diluted earnings per share were $0.63, a decrease of 17.4%, compared to $0.76 for the first quarter of 2008. The company reported

Orphan drug designation entitles Antigenics to seven years of market exclusivity for Oncophage in the treatment of glioma patients in the event of market approval for this indication.

Revenues for the first quarter of 2009 were $3.16 million, compared to $2.76 million for the same period in 2008. First quarter 2009 revenues were primarily from Sangamo’s